Adjuvant treatment for Stage i seminoma

Why radiotherapy is better than carboplatin

Prahlad Yathiraj, Krishna Sharan, Donald Fernandes, M. Vidyasagar

Research output: Contribution to journalReview article

Abstract

Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.

Original languageEnglish
Pages (from-to)1216-1219
Number of pages4
JournalJournal of Cancer Research and Therapeutics
Volume12
Issue number4
DOIs
Publication statusPublished - 01-10-2016

Fingerprint

Seminoma
Carboplatin
Radiotherapy
Drug Therapy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

@article{7b71654936524fab85939d417f5e3f0e,
title = "Adjuvant treatment for Stage i seminoma: Why radiotherapy is better than carboplatin",
abstract = "Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.",
author = "Prahlad Yathiraj and Krishna Sharan and Donald Fernandes and M. Vidyasagar",
year = "2016",
month = "10",
day = "1",
doi = "10.4103/0973-1482.176171",
language = "English",
volume = "12",
pages = "1216--1219",
journal = "Journal of Cancer Research and Therapeutics",
issn = "0973-1482",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "4",

}

Adjuvant treatment for Stage i seminoma : Why radiotherapy is better than carboplatin. / Yathiraj, Prahlad; Sharan, Krishna; Fernandes, Donald; Vidyasagar, M.

In: Journal of Cancer Research and Therapeutics, Vol. 12, No. 4, 01.10.2016, p. 1216-1219.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Adjuvant treatment for Stage i seminoma

T2 - Why radiotherapy is better than carboplatin

AU - Yathiraj, Prahlad

AU - Sharan, Krishna

AU - Fernandes, Donald

AU - Vidyasagar, M.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.

AB - Adjuvant treatment options for Stage I seminoma include active surveillance, chemotherapy, and radiotherapy. Active surveillance may not be ideal for the average Indian patient. Of the two accepted adjuvant therapy options, namely single-dose carboplatin chemotherapy and radiotherapy to the retroperitoneal nodes, though it intuitively appears more appealing, a deeper review reveals the potential drawbacks of chemotherapy. This article highlights the misconceptions regarding carboplatin and provides reasons for an argument why radiotherapy is better when a patient with Stage I seminoma chooses to undergo adjuvant treatment.

UR - http://www.scopus.com/inward/record.url?scp=85012134744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012134744&partnerID=8YFLogxK

U2 - 10.4103/0973-1482.176171

DO - 10.4103/0973-1482.176171

M3 - Review article

VL - 12

SP - 1216

EP - 1219

JO - Journal of Cancer Research and Therapeutics

JF - Journal of Cancer Research and Therapeutics

SN - 0973-1482

IS - 4

ER -